EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.21.1 | Aberrant Crypt Foci |
9570361 |
Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. |
ongoing research unassigned |
3 0 |
3.1.21.1 | Aberrant Crypt Foci |
9781370 |
Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats. |
ongoing research unassigned |
4 0 |
3.1.21.1 | Aberrant Crypt Foci |
10025873 |
Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. |
ongoing research therapeutic application unassigned |
3 1 0 |
3.1.21.1 | Aberrant Crypt Foci |
12079509 |
Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. |
causal interaction ongoing research unassigned |
2 3 0 |
3.1.21.1 | Aberrant Crypt Foci |
15312680 |
Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. |
ongoing research therapeutic application unassigned |
4 2 0 |
3.1.21.1 | Abscess |
5803942 |
[Therapy of pelvic abscess by the vaginal route using streptokinase and streptodornase] |
therapeutic application unassigned |
4 0 |
3.1.21.1 | Abscess |
7452353 |
Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. |
causal interaction therapeutic application unassigned |
4 2 0 |
3.1.21.1 | Abscess |
9093012 |
Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis. |
causal interaction diagnostic usage therapeutic application unassigned |
4 2 1 0 |
3.1.21.1 | Abscess |
9195073 |
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. |
therapeutic application unassigned |
2 0 |
3.1.21.1 | Abscess |
14941322 |
The use of streptokinase and streptodornase in pelvic abscesses; preliminary report. |
causal interaction therapeutic application unassigned |
1 3 0 |